XML 71 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions - Schedule of Consideration Paid for IPR&D (Detail) - QrumPharma
$ in Thousands
1 Months Ended
Dec. 31, 2020
USD ($)
Business Acquisition [Line Items]  
Cash consideration $ 3,574
Stock consideration (3,067,179 shares at $3.01 per share) 9,250
Transaction costs 531
Repayment of debt 11
Liabilities assumed 22
Cash acquired (155)
Total consideration paid for IPR&D $ 13,233